(Q54465363)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242618%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Differential expression of immune-related markers in breast cancer by molecular phenotypes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242618%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242618%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Junjeong Choi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242618%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Do Hee Kim

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242618%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Woo Hee Jung

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242618%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

English

0 references

publication date

16 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242618%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242618%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242618%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242618%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

417-429

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242618%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-012-2383-z

20 February 2020

exact match

0 references

cites work

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

Gene expression predictors of breast cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

Distinctive gene expression patterns in human mammary epithelial cells and breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

STATs: signal transducers and activators of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

A clinically relevant gene signature in triple negative and basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

Gene expression profiling of breast cell lines identifies potential new basal markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

Persistent and non-persistent changes in gene expression result from long-term estrogen exposure of MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

Molecular heterogeneity of triple-negative breast cancer and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

The interleukin-8 pathway in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

ERβ and PEA3 co-activate IL-8 expression and promote the invasion of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

Interleukin-8 is associated with adhesion, migration and invasion in human gastric cancer SCG-7901 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

Interleukin-8 derived from local tissue-resident stromal cells promotes tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

STAT proteins as novel targets for cancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2383-Z